Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

Stress affects skin health, and mental health support is crucial for patients with skin conditions.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

PRP improves hair transplant results in androgenetic alopecia patients.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

A woman's hair loss was misdiagnosed as alopecia areata but was actually lichen planopilaris, needing immediate and ongoing treatment.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

The Sinclair Shedding Scale is effective for diagnosing Alopecia Areata Incognita and monitoring treatment success.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

The black orchid Brasiliorchis schunkeana produces chemicals that attract certain insects and have potential antimicrobial properties.

PCOS affects many aspects of health, not just fertility, and needs comprehensive treatment.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Cyclosporin A and FK506 can start new hair growth in mice, but ascomycin and rapamycin cannot.

Use minoxidil for hair loss; finasteride and dutasteride for men, dutasteride for women.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

Minoxidil helps stabilize hair loss, increase density, and reduce shedding after hair transplant surgery.

Polygonum multiflorum can promote hair growth when taken orally or applied topically.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Male hormones control a specific gene in hamster skin, with different hormones having varying effects.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

New treatments for skin diseases are more effective and patient-friendly, but many still lack a cure.

Early treatment and weight management are important for teenagers with PCOS to reduce symptoms and long-term health risks.

Minoxidil caused hair to grow in unintended areas, like a tail, in a young girl.

Treat hair loss with medicine, continue indefinitely.

Low-dose oral minoxidil is effective and safe for hair loss, but more research is needed.